Investing Ideas
/
Indonesian Pharmaceuticals & Biotech High Return On Equity, Low Debt

Indonesian Pharmaceuticals & Biotech High Return On Equity, Low Debt

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

Merck

Market Cap: Rp1.8t

Engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally.

MERK

Rp3,910.00

-0.5%

39.1%